MIRA Prescription drugs inventory rated ‘Purchase’, cites pre-clinical developments – Ascendiant By Investing.com
On Monday, Ascendiant Capital initiated protection on NASDAQ:MIRA, MIRA Prescription drugs Inc.…
By
Tycoon Herald
5 Min Read